Journal article
Clinical intensity modulated proton therapy for Hodgkin lymphoma: which patients benefit the most?
- Abstract:
-
Purpose
Radiation therapy (RT) improves control of Hodgkin lymphoma (HL), but patients who undergo RT are at risk for late effects, including cardiovascular disease and second cancers, because of radiation doses to organs at risk (OARs). Proton therapy (PT) can reduce OAR doses compared with conventional photon RT. However, access to PT is currently limited, so referrals must be appropriately selective. We aimed to identify subgroups of patients with HL who could be...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Practical Radiation Oncology Journal website
- Volume:
- 9
- Issue:
- 3
- Pages:
- 179-187
- Publication date:
- 2019-01-29
- Acceptance date:
- 2019-01-16
- DOI:
- EISSN:
-
1879-8519
- ISSN:
-
1879-8500
- Pmid:
-
30708133
- Source identifiers:
-
969110
Item Description
- Pubs id:
-
pubs:969110
- UUID:
-
uuid:1b433cb9-162d-4cdb-baa0-b2f12e7ea0d5
- Local pid:
- pubs:969110
- Deposit date:
- 2019-05-28
Terms of use
- Copyright holder:
- Ntentas, G, et al
- Copyright date:
- 2019
- Notes:
- © 2019 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. This is an open access article under the CC BY license.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record